ERBB2 and breast adenocarcinoma: In this study the synthesis of a fluorescent or radio-labeled Trastuzumab-PEI and in vitro uptake, and binding affinity to the Her2/neu expressing human breast adenocarcinoma SKBr3 cells is discussed.